Does the proteasome inhibitor bortezomib sensitize to DNA- damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo
F Briest, EJ Koziolek, J Albrecht, F Schmidt, Monique Bernsen, Joost Haeck, AA Kuhl, D Sedding, T Hartung, S Exner, M Welzel, C Fischer, C Grotzinger, W Brenner, RP Baum, P Grabowski
Research output: Contribution to journal › Article › Academic › peer-review
10Citations
(Scopus)
128Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Does the proteasome inhibitor bortezomib sensitize to DNA- damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo'. Together they form a unique fingerprint.